Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1992-4-17
pubmed:abstractText
The inducible pleiotropic transcription factor NF-kappa B is composed of two subunits, p50 and p65. The p50 subunit is encoded on the N-terminal half of a 105-kDa open reading frame and contains a rel-like domain. To date, no function has been described for the C-terminal portion. We show here that the C-terminal half of p105, when expressed as a separate molecule, binds to p50 and can rapidly disrupt protein-DNA complexes of p50 or native NF-kappa B. Deletion analysis of this precursor-derived inhibitor activity indicated a domain containing ankyrin-like repeats as necessary for inhibition. The protooncogene bcl-3, which contains seven ankyrin repeats, can equally inhibit p50 DNA binding. These observations identify bcl-3 as an inhibitor of NF-kappa B and strongly suggest that the ankyrin repeats in these factors are involved in protein-protein interactions with the rel-like domain of p50. Comparison with other ankyrin repeat-containing proteins suggests that a subclass of these proteins acts as regulators of rel-like transcription factors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1675604, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1829648, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1851550, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1876189, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1876833, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-1992489, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2001394, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2001591, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2006423, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2068782, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2137557, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2141335, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2157987, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2180580, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2184941, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2199796, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2203531, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2203532, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2234062, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2317869, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2532066, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2665943, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2689885, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2758466, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-2821408, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-3097517, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-3119226, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-3133660, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-3419531, http://linkedlifedata.com/resource/pubmed/commentcorrection/1532257-4018034
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
89
pubmed:geneSymbol
bcl-3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2489-93
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1532257-Amino Acid Sequence, pubmed-meshheading:1532257-Ankyrins, pubmed-meshheading:1532257-Blood Proteins, pubmed-meshheading:1532257-Cell Line, pubmed-meshheading:1532257-DNA-Binding Proteins, pubmed-meshheading:1532257-Gene Expression Regulation, Neoplastic, pubmed-meshheading:1532257-HeLa Cells, pubmed-meshheading:1532257-Humans, pubmed-meshheading:1532257-Macromolecular Substances, pubmed-meshheading:1532257-Membrane Proteins, pubmed-meshheading:1532257-Molecular Sequence Data, pubmed-meshheading:1532257-NF-kappa B, pubmed-meshheading:1532257-NF-kappa B p50 Subunit, pubmed-meshheading:1532257-Protein Precursors, pubmed-meshheading:1532257-Proto-Oncogene Proteins, pubmed-meshheading:1532257-Proto-Oncogenes, pubmed-meshheading:1532257-Repetitive Sequences, Nucleic Acid, pubmed-meshheading:1532257-Sequence Homology, Nucleic Acid, pubmed-meshheading:1532257-Transcription Factors
pubmed:year
1992
pubmed:articleTitle
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
More...